Obagi Medical (OMPI +7.7%) moves up today after topping Q4 estimates late yesterday. Looking...


Obagi Medical (OMPI +7.7%) moves up today after topping Q4 estimates late yesterday. Looking forward, the company sees FY13 earnings of $0.80 to $0.84 per share on $126M to $130M. The Street is at $0.88 per share and $128.31M in revenue. Cantor Fitzgerald upgraded the shares to Buy on the back of the report and raised its price target from $15.00 to $19.00, noting a 50% probability of a takeout in the $21 range.

From other sites
Comments (1)
  • GaryLee276
    , contributor
    Comments (151) | Send Message
     
    I bought OMPI because it was a solid stock with a possibility it might be bought out. So far so good. Help me please!!!!
    15 Mar 2013, 11:47 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs